HPV Vaccine Hesitancy Among Female Students in China Increases Despite Improved Knowledge
HPV vaccine hesitancy among female university students in China rose from 8.8% to 21.6% between 2022 and 2025, despite improved knowledge.
Indication
Clinical and regulatory intelligence for Cervical Cancer with 10 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.